Table 3.
Rhythm control strategies and patient-reported outcomes in propensity score matched cohorts
Function |
Anxiety |
Depression |
Symptoms |
AF-related QOL |
|
---|---|---|---|---|---|
(β, 95% CI) | (β, 95% CI) | (β, 95% CI) | (β, 95% CI) | (β, 95% CI) | |
Rhythm control strategy* | 0.20 (−0.99 to 1.40) | −0.44 (−1.66 to 0.78) | −0.39 (−1.53 to 0.76) | 0.00 (−21 to 0.22) | −3.23 (−6.78 to 0.32) |
Sex | −2.33 (−3.57 to 1.08) | 2.25 (0.99 to 3.50) | 1.51 (0.32 to 2.70) | 0.28 (0.05 to 0.50) | −4.64 (−8.28 to 1.01) |
Age | −0.19 (−0.25 to 0.13) | −0.14 (−0.20 to 0.08) | −0.12 (−0.17 to 0.06) | −0.03 (−0.04 to 0.02) | 0.18 (0.01 to 0.36) |
Education level | |||||
>Than college | Ref | Ref | Ref | Ref | Ref |
College | −1.95 (−3.49 to 0.42) | −0.10 (−1.67 to 1.46) | 0.31 (−1.16 to 1.77) | 0.04 (−0.23 to 0.31) | −0.42 (−4.93 to 4.09) |
Some college | −1.76 (−3.31 to 0.20) | 1.51 (−0.07 to 3.08) | 1.15 (−0.33 to 2.63) | 0.42 (0.14 to 0.70) | −6.11 (−10.58 to 11.65- |
High school or less | −2.46 (−4.26 to 0.66) | −0.04 (−1.87 to 1.79) | 0.52 (−1.20 to 2.24) | 0.13 (−0.18 to 0.43) | −3.09 (−8.09 to 1.90) |
Comorbidity index | |||||
0 | Ref | Ref | Ref | Ref | Ref |
1 | −0.76 (−2.31 to 0.79) | 0.93 (−0.65 to 2.51) | 1.17 (−0.30 to 2.64) | −0.26 (−1.37 to 0.85) | −0.82 (−5.32 to 3.68) |
2 | −2.47 (−3.79 to 1.15) | 0.76 (−0.59 to 2.11) | 1.60 (0.34 to 2.86) | −0.01 (−1.11 to 1.08) | −5.89 (−9.81 to 1.97) |
BMI | |||||
Normal | Ref | Ref | Ref | Ref | Ref |
Overweight | 0.70 (−0.94 to 2.34) | 0.38 (−1.29 to 2.05) | −0.38 (−1.95 to 1.18) | −0.12 (−0.0 to 0.17) | −0.18 (−5.05 to 4.68) |
Obese | −2.76 (−4.37 to 1.16) | 0.76 (−0.89 to 2.42) | 0.03 (−1.50 to 1.56) | 0.12 (0.26 to 0.30) | −6.18 (−10.93 to 1.43) |
Rhythm control strategy included cardioversion, ablation and rhythm control medications.
BMI, body mass index; QOL, quality of life.